Glenmede Trust’s Anika Therapeutics ANIK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q4
Sell
-238
Closed -$8K 1243
2020
Q3
$8K Sell
238
-58
-20% -$1.95K ﹤0.01% 1936
2020
Q2
$11K Buy
296
+147
+99% +$5.46K ﹤0.01% 1811
2020
Q1
$7K Hold
149
﹤0.01% 2544
2019
Q4
$7K Buy
149
+50
+51% +$2.35K ﹤0.01% 2544
2019
Q3
$5 Buy
99
+45
+83% +$2 ﹤0.01% 2612
2019
Q2
$2 Sell
54
-296
-85% -$11 ﹤0.01% 2830
2019
Q1
$9 Sell
350
-405
-54% -$10 ﹤0.01% 2390
2018
Q4
$25 Buy
+755
New +$25 ﹤0.01% 1882
2018
Q3
Sell
-1,304
Closed -$42K 1450
2018
Q2
$42K Sell
1,304
-97
-7% -$3.12K ﹤0.01% 1497
2018
Q1
$75K Hold
1,401
﹤0.01% 1483
2017
Q4
$75K Sell
1,401
-250
-15% -$13.4K ﹤0.01% 1483
2017
Q3
$95K Sell
1,651
-590
-26% -$33.9K ﹤0.01% 1438
2017
Q2
$97K Hold
2,241
﹤0.01% 1390
2017
Q1
$97K Sell
2,241
-400
-15% -$17.3K ﹤0.01% 1390
2016
Q4
$129K Sell
2,641
-4,100
-61% -$200K ﹤0.01% 1326
2016
Q3
$322K Sell
6,741
-2,500
-27% -$119K ﹤0.01% 1053
2016
Q2
$495K Sell
9,241
-1,607
-15% -$86.1K ﹤0.01% 926
2016
Q1
$485K Sell
10,848
-2,080
-16% -$93K ﹤0.01% 926
2015
Q4
$493K Buy
12,928
+4,296
+50% +$164K ﹤0.01% 919
2015
Q3
$274K Sell
8,632
-11,782
-58% -$374K ﹤0.01% 1107
2015
Q2
$674K Buy
20,414
+831
+4% +$27.4K ﹤0.01% 838
2015
Q1
$805K Buy
19,583
+7,282
+59% +$299K 0.01% 822
2014
Q4
$501K Hold
12,301
﹤0.01% 956
2014
Q3
$450K Hold
12,301
﹤0.01% 912
2014
Q2
$569K Sell
12,301
-2,000
-14% -$92.5K 0.01% 828
2014
Q1
$587K Buy
14,301
+4,041
+39% +$166K 0.01% 826
2013
Q4
$391K Hold
10,260
﹤0.01% 931
2013
Q3
$245K Sell
10,260
-5,000
-33% -$119K ﹤0.01% 1057
2013
Q2
$259K Buy
+15,260
New +$259K ﹤0.01% 999